A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

NCT05536791 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No patients were screened in the study.

Conditions

Venous Thromboembolism

Interventions

DRUG: Dabigatran Etexilate (DE)

Sponsor

Boehringer Ingelheim